Останні дані на
Останні дані на 12.07.2022
The purpose of the investment policy of the management company is to ensure that changes in the settlement price correspond to changes in quantitative indicators of changes in prices for units (shares) of the ARK Genomic Revolution ETF.
The ATON - Genetic Revolution is a(n) Equity Exchange Traded Investment Funds (ETIF) seeks to invest in Biotech sector located in USA. The Aton Management fund’s base currency is USD and the share class was registered 09.04.2021 with unique ISIN - RU000A102XN5. The total expense ratio is 0.95%. The ATON - Genetic Revolution pays dividends 0 time(s) per year.